Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBALIZUMAB-UIYK vs IBREXAFUNGERP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBALIZUMAB-UIYK vs IBREXAFUNGERP: Safety Overview

Metric IBALIZUMAB-UIYK IBREXAFUNGERP
Total FAERS Reports 418 129
Deaths Reported 31 6
Death Rate 7.4% 4.7%
Hospitalizations 94 9
Average Patient Age 56.0 yrs 44.4 yrs
% Female Patients 22.8% 85.2%
FDA Approval Date N/A Jun 1, 2021
Marketing Status Prescription Prescription